Comparison of resmetirom quantative analysis in API and formulation models based on PXRD, FTIR and Raman scanning imaging combined with univariate and multivariate analyses

Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperatur...

Full description

Saved in:
Bibliographic Details
Published inTalanta (Oxford) Vol. 287; p. 127568
Main Authors Yang, Chen, Luo, Ying, Sun, Wenxia, Liu, Xiangkui, Zhu, Xueyan
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.05.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated). [Display omitted] •First report of resmetirom polymorph qualification in formulation models.•The Raman spectra of resmetirom of dihydrate and the anhydrous forms was reported for the first time.•Univariate and multivariate analytical models were established and compared.•PLSR models were constructed combined with pre-processing methods.
AbstractList Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated).Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated).
Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R  = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R  = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated).
Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H2O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R2 = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R2 = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated). [Display omitted] •First report of resmetirom polymorph qualification in formulation models.•The Raman spectra of resmetirom of dihydrate and the anhydrous forms was reported for the first time.•Univariate and multivariate analytical models were established and compared.•PLSR models were constructed combined with pre-processing methods.
Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H₂O, were mentioned in the original patent. The commercially available crystal form of resmetirom was form I. However, the tablets were subject to temperature, pressure, and humidity, and may be converted to form-2H₂O, which affects the bioavailability and efficacy. Therefore, it is crucial to establish a suitable crystalline quantification method to examine the concentration of both crystalline forms in APIs and formulations. The main objective of this paper was to test the feasibility of PXRD, FTIR and Raman for quantitative analysis of form I content in API and formulation models. Commonly used methods to establish quantitative modelling were univariate and multivariate analyses, due to the overlapping peaks in the FTIR and Raman spectra of two forms, only the multivariate method, with partial least squares regression (PLSR), was used, both univariate and multivariate analysis were utilized in PXRD since it has distinct single peaks. In the multivariate models, the raw spectra are preprocessed to remove interfering information and spectral noise by nine commonly used pretreatment methods. According to the result of this study, all four calibration models could be applied to the quantitative analysis of form I in two models; however, Raman was found to be the most appropriate model for both API model (Y = 0.99523X+0.00300, R² = 0.9997, RMSECV = 9.32 %, RESEP = 0.29 %, RESEC = 0.19 %, LOD = 3.2819 %, LOQ = 9.9451 %, MSC pretreated) and formulation model (Y = 0.99456X+0.00331, R² = 0.9996, RMSECV = 1.14 %, RESEP = 0.39 %, RESEC = 0.01 %, LOD = 3.3098 %, LOQ = 9.1029 %, WT pretreated).
ArticleNumber 127568
Author Zhu, Xueyan
Yang, Chen
Sun, Wenxia
Liu, Xiangkui
Luo, Ying
Author_xml – sequence: 1
  givenname: Chen
  surname: Yang
  fullname: Yang, Chen
  organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China
– sequence: 2
  givenname: Ying
  surname: Luo
  fullname: Luo, Ying
  organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China
– sequence: 3
  givenname: Wenxia
  surname: Sun
  fullname: Sun, Wenxia
  organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China
– sequence: 4
  givenname: Xiangkui
  surname: Liu
  fullname: Liu, Xiangkui
  email: liuxiangkui@sinopharm.com
  organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China
– sequence: 5
  givenname: Xueyan
  surname: Zhu
  fullname: Zhu, Xueyan
  organization: Shanghai Institute of Pharmaceutical Industry Co.,Ltd., 285 Gebaini Road, Shanghai, 201203, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39923672$$D View this record in MEDLINE/PubMed
BookMark eNqFkc9u1DAQxi1URLeFRwD5yIEs_pM4yQlVW1pWqkS1KhI3y7EnxavY3trJor4TD1mnuyBuPY1m5vd9tuY7Qyc-eEDoPSVLSqj4vF2OalB-VEtGWLWkrK5E8wotaFPzglc1P0ELQnhbtLQkp-gspS0hhHHC36BT3raMi5ot0J9VcDsVbQoehx5HSA5GG4PDD9PsPto9YOXV8Jhswtbji9t17g3uQ3TTkPdZ6IKBIeFOJTA497c_N5ef8NXdevOMbpRTHietvLf-Hlun7ueqg-usz4rfdvyFJ2_3-R9qhGdN9h7_G8zvQ3qLXvdqSPDuWM_Rj6uvd6tvxc336_Xq4qbQvBRjwfpGUGB1D6CMIUQbRjUxtSj7uuKcNW3fCtV0ddlp3RgBdWOqind9SWhPCPBz9PHgu4vhYYI0SmeThiHfG8KUJGclI1UriHgZpaIiTQZn9MMRnToHRu5ivkR8lH_DyEB1AHQMKUXo_yGUyDl0uZXH0OUcujyEnnVfDrocAuwtRJm0Ba_B2Ah6lCbYFxyeABF8ugA
Cites_doi 10.1016/j.xphs.2019.06.024
10.1016/S0165-9936(02)01208-6
10.1016/j.jpba.2009.09.021
10.1364/AO.463293
10.1111/liv.15930
10.1016/j.saa.2024.124858
10.1016/S0169-7439(01)00155-1
10.1016/S0169-409X(01)00099-0
10.2174/2210309005666150128003150
10.1002/jps.24160
10.1016/j.powtec.2018.06.025
10.1016/j.jpba.2008.11.033
10.1038/s41591-023-02603-1
10.1016/j.saa.2023.122458
10.3390/ijms23169013
10.1016/j.ijpharm.2008.10.010
10.1016/S0003-2670(96)00425-4
10.1016/j.isci.2022.105871
10.5740/jaoacint.19-0201
10.1016/j.saa.2020.118900
10.1016/j.jpba.2006.08.030
10.1016/j.jpba.2010.12.020
10.1016/j.talanta.2019.03.027
10.1023/A:1018956304595
10.1016/j.ijpharm.2010.07.043
10.1016/j.jpba.2012.01.013
10.1016/j.foodchem.2023.137300
10.1016/S0731-7085(02)00053-5
10.1016/j.saa.2022.120996
10.1016/j.jpba.2015.06.011
10.1016/j.jpba.2015.01.005
10.1080/03639045.2023.2290021
10.1016/S0378-5173(98)00335-4
10.1177/00037028231152497
10.1016/j.jpba.2013.12.001
10.1016/j.jpba.2017.02.053
10.1007/s00223-007-9007-3
10.1016/j.jpba.2008.09.054
10.1016/j.ssnmr.2011.03.007
10.1016/j.molliq.2022.120857
10.1002/biot.200900284
10.1016/j.jpba.2018.05.026
10.1016/j.xphs.2022.09.009
10.1016/j.cclet.2016.03.042
10.1186/s13065-021-00752-3
ContentType Journal Article
Copyright 2025
Copyright © 2025. Published by Elsevier B.V.
Copyright_xml – notice: 2025
– notice: Copyright © 2025. Published by Elsevier B.V.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.talanta.2025.127568
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1873-3573
ExternalDocumentID 39923672
10_1016_j_talanta_2025_127568
S0039914025000542
Genre Journal Article
Comparative Study
GroupedDBID --K
--M
-DZ
-~X
.~1
0R~
123
1B1
1RT
1~.
1~5
4.4
457
4G.
5VS
7-5
71M
8P~
9JN
AABNK
AAEDT
AAEDW
AAHBH
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATTM
AAXKI
AAXUO
AAYWO
ABJNI
ABMAC
ACDAQ
ACGFS
ACNCT
ACRLP
ACVFH
ADBBV
ADCNI
ADECG
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFJKZ
AFPUW
AFTJW
AFXIZ
AFZHZ
AGCQF
AGHFR
AGRNS
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJSZI
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M36
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
RNS
ROL
RPZ
SCC
SCH
SDF
SDG
SDP
SES
SEW
SPC
SPCBC
SSH
SSK
SSZ
T5K
TN5
TWZ
WH7
XPP
YK3
YNT
ZMT
~02
~G-
29Q
3O-
53G
AAQXK
AAYJJ
AAYXX
ABDPE
ABEFU
ABFNM
ABWVN
ABXDB
ACNNM
ACRPL
ADIYS
ADMUD
ADNMO
AGQPQ
AJQLL
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
FGOYB
HMU
HVGLF
HZ~
R2-
RIG
SCB
WUQ
XOL
AACTN
CGR
CUY
CVF
ECM
EIF
K-O
NPM
7X8
7S9
EFKBS
L.6
ID FETCH-LOGICAL-c346t-2f861e27feeadd00cd21c0d764f7533289f96a8b74bcc8d6e78d553bf401f00e3
IEDL.DBID .~1
ISSN 0039-9140
1873-3573
IngestDate Fri Aug 22 20:24:55 EDT 2025
Fri Jul 11 04:21:09 EDT 2025
Fri May 09 01:30:34 EDT 2025
Thu Jul 03 08:26:57 EDT 2025
Sat Jul 05 17:11:13 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords Resmetirom
Raman
Quantitative
FTIR
Polymorphism
PXRD
Language English
License Copyright © 2025. Published by Elsevier B.V.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c346t-2f861e27feeadd00cd21c0d764f7533289f96a8b74bcc8d6e78d553bf401f00e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 39923672
PQID 3165080636
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3242059606
proquest_miscellaneous_3165080636
pubmed_primary_39923672
crossref_primary_10_1016_j_talanta_2025_127568
elsevier_sciencedirect_doi_10_1016_j_talanta_2025_127568
PublicationCentury 2000
PublicationDate 2025-05-15
PublicationDateYYYYMMDD 2025-05-15
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-15
  day: 15
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Talanta (Oxford)
PublicationTitleAlternate Talanta
PublicationYear 2025
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Shi, Wang, Wang, Song, Liu, Wu, Gong (bib10) 2021; 14
Schulz, Pretzsch, Khalaf, Deiwick, Scheidt, Salis-Soglio, Bader, Huster (bib28) 2007 Apr; 80
Saha, Singh, Paul, Sarkar, Khan, Banerjee (bib20) 2020 Jan 1; 103
Vankeirsbilck, Vercauteren, Baeyens, Van der Weken, Verpoort, Vergote, Remon (bib51) 2002; 21
Liu, Liu, Wang, Song, Li, Wu, Gong (bib11) 2023 May 15; 293
Breitenbach, Schrof, Neumann (bib52) 1999 Jul; 16
Chieng, Rehder, Saville, Rades, Aaltonen (bib22) 2009 Jan 15; 49
Chen, Stowell, Morris, Byrn (bib38) 2010 Mar 11; 51
Bansal, Singh, Kaur (bib17) 2021 Apr 24; 15
Takehira, Momose, Yamamura (bib39) 2010 Oct 15; 398
Bhavana, Chavan, Mannava, Nangia, Shastri (bib19) 2019 Jul 1; 199
Wu, Du, Ma, Zhang, Yang, Liu, Zhang (bib26) 2024 Feb 1; 433
Wang, Shi, Hou, Li, Wang, Yang, Cao (bib29) 2023 Feb 15; 287
Hurst, Schroeder, Styron (bib42) 1997; 337
(bib1) 2006
Meng, Ciyong, Li, Zhao, Zhang, Du (bib21) 2022 Jul 20; 61
Német, Kis, Pokol, Demeter (bib40) 2009 Feb 20; 49
Bakkar, Nawaz, Majeed, Naseem, Ditta, Rashid, Ali, Bajwa, Bashir, Ahmad, Hyat, Bukhari, Bonnier (bib41) 2021 Jan 15; 245
Takehira, Momose, Yamamura (bib43) 2010 Oct 15; 398
Skrdla, Zhang (bib34) 2014 Mar; 90
Inoue, Osada, Hisada, Koide, Fukami, Roy, Carriere (bib24) 2023 Jan; 112
Shafaq, Majeed, Nawaz (bib45) 2022; 272
Braga, Casali, Grepioni (bib2) 2022 Aug 12; 23
Tian, Luo, Lou (bib8) 2023; 369
Tiwari, Chawla, Bansal (bib37) 2007 Feb 19; 43
Wold, Sjöström, Eriksson (bib46) 2001; 58
Campbell Roberts, Williams, Grimsey, Booth (bib36) 2002 Jun 15; 28
Croker, Hennigan, Maher, Hu, Ryder, Hodnett (bib49) 2012 Apr 7; 63
Zhao, Zheng, Li (bib13) 2016; 27
Sheokand, Modi, Bansal (bib33) 2014 Nov; 103
Tiwari, Chawla, Bansal (bib50) 2007 Feb 19; 43
Bellur Atici, Karlığa (bib16) 2015 Oct 10; 114
Qiu, Li, Sheng, Zhu (bib44) 2015 Mar 25; 107
Guirguis, Dougherty, Thornby, Grace, Mack (bib7) 2024 Jun; 17
Németh, Rákosa (bib47) 2023 Apr; 77
Ji, Zhu, Deng, Jiang, Chen (bib15) 2024 Dec 15; 323
Harrison, Taub, Neff, Lucas, Labriola, Moussa, Alkhouri, Bashir (bib6) 2023 Nov; 29
Dharani, Barakh Ali, Afrooz, Khan, Rahman (bib14) 2019 Nov; 108
Ghafoor, Kanwal, Nawaz, Irfan Majeed, Rashid, Ishtiaq, Tariq, Kainat, Ali, Anwar, Shoukat, Amir, Imran (bib25) 2024 Jan; 50
Guo, Luo, Zhou (bib35) 2017; 140
Buckton, D (bib12) 1999; 179
Achata, Esquerre, Gowen (bib18) 2018; 336
Kang, Shao, Wang, Hu, Yu (bib23) 2018 Sep 5; 158
Jiang, Huang, Dai, Hunger (bib27) 2011 May-Jun; 39
Xiong, Huaxin, Wu (bib31) 2015; 50
Petta, Targher, Romeo, Pajvani, Zheng, Aghemo, Valenti (bib5) 2024 Jul; 44
Shi, Li, Wang, Wang, Yang (bib30) 2022 Dec 24; 26
Mahmoudi, Fattahi-Asl, Hosseinzadeh (bib9) 2014; 4
Chieng, Rades, Aaltonen (bib32) 2011 Jun 25; 55
Zhao, Zhang, Liu (bib48) 2010 May; 5
Kamada, Yoshimura, Murata, Murata, Nagai, Ushio, Terada (bib4) 2009 Feb 23; 368
Stephenson, Forbes, Reutzel-Edens (bib3) 2001 May 16; 48
Vankeirsbilck (10.1016/j.talanta.2025.127568_bib51) 2002; 21
Wang (10.1016/j.talanta.2025.127568_bib29) 2023; 287
Tiwari (10.1016/j.talanta.2025.127568_bib50) 2007; 43
Schulz (10.1016/j.talanta.2025.127568_bib28) 2007; 80
Croker (10.1016/j.talanta.2025.127568_bib49) 2012; 63
Shafaq (10.1016/j.talanta.2025.127568_bib45) 2022; 272
Sheokand (10.1016/j.talanta.2025.127568_bib33) 2014; 103
Zhao (10.1016/j.talanta.2025.127568_bib13) 2016; 27
Bellur Atici (10.1016/j.talanta.2025.127568_bib16) 2015; 114
Mahmoudi (10.1016/j.talanta.2025.127568_bib9) 2014; 4
Zhao (10.1016/j.talanta.2025.127568_bib48) 2010; 5
Buckton (10.1016/j.talanta.2025.127568_bib12) 1999; 179
Bansal (10.1016/j.talanta.2025.127568_bib17) 2021; 15
Takehira (10.1016/j.talanta.2025.127568_bib43) 2010; 398
Bhavana (10.1016/j.talanta.2025.127568_bib19) 2019; 199
Harrison (10.1016/j.talanta.2025.127568_bib6) 2023; 29
Qiu (10.1016/j.talanta.2025.127568_bib44) 2015; 107
Petta (10.1016/j.talanta.2025.127568_bib5) 2024; 44
Wold (10.1016/j.talanta.2025.127568_bib46) 2001; 58
Chieng (10.1016/j.talanta.2025.127568_bib32) 2011; 55
Chieng (10.1016/j.talanta.2025.127568_bib22) 2009; 49
Ghafoor (10.1016/j.talanta.2025.127568_bib25) 2024; 50
Kamada (10.1016/j.talanta.2025.127568_bib4) 2009; 368
Kang (10.1016/j.talanta.2025.127568_bib23) 2018; 158
Jiang (10.1016/j.talanta.2025.127568_bib27) 2011; 39
Stephenson (10.1016/j.talanta.2025.127568_bib3) 2001; 48
Shi (10.1016/j.talanta.2025.127568_bib10) 2021; 14
Hurst (10.1016/j.talanta.2025.127568_bib42) 1997; 337
Tian (10.1016/j.talanta.2025.127568_bib8) 2023; 369
Wu (10.1016/j.talanta.2025.127568_bib26) 2024; 433
Saha (10.1016/j.talanta.2025.127568_bib20) 2020; 103
Achata (10.1016/j.talanta.2025.127568_bib18) 2018; 336
Chen (10.1016/j.talanta.2025.127568_bib38) 2010; 51
Német (10.1016/j.talanta.2025.127568_bib40) 2009; 49
Liu (10.1016/j.talanta.2025.127568_bib11) 2023; 293
Guo (10.1016/j.talanta.2025.127568_bib35) 2017; 140
Skrdla (10.1016/j.talanta.2025.127568_bib34) 2014; 90
Németh (10.1016/j.talanta.2025.127568_bib47) 2023; 77
Inoue (10.1016/j.talanta.2025.127568_bib24) 2023; 112
Campbell Roberts (10.1016/j.talanta.2025.127568_bib36) 2002; 28
Takehira (10.1016/j.talanta.2025.127568_bib39) 2010; 398
Guirguis (10.1016/j.talanta.2025.127568_bib7) 2024; 17
Bakkar (10.1016/j.talanta.2025.127568_bib41) 2021; 245
Tiwari (10.1016/j.talanta.2025.127568_bib37) 2007; 43
Braga (10.1016/j.talanta.2025.127568_bib2) 2022; 23
Xiong (10.1016/j.talanta.2025.127568_bib31) 2015; 50
Breitenbach (10.1016/j.talanta.2025.127568_bib52) 1999; 16
Ji (10.1016/j.talanta.2025.127568_bib15) 2024; 323
Dharani (10.1016/j.talanta.2025.127568_bib14) 2019; 108
Shi (10.1016/j.talanta.2025.127568_bib30) 2022; 26
Meng (10.1016/j.talanta.2025.127568_bib21) 2022; 61
(10.1016/j.talanta.2025.127568_bib1) 2006
References_xml – volume: 28
  start-page: 1149
  year: 2002 Jun 15
  end-page: 1159
  ident: bib36
  article-title: Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry--exploring preferred orientation effects
  publication-title: J. Pharm. Biomed. Anal.
– volume: 17
  year: 2024 Jun
  ident: bib7
  article-title: Resmetirom: the first food and drug administration-approved medication for nonalcoholic steatohepatitis (NASH)
  publication-title: Ann. Pharmacother.
– volume: 21
  start-page: 869
  year: 2002
  end-page: 877
  ident: bib51
  article-title: Applications of Raman spectroscopy in pharmaceutical analysis
  publication-title: TrAC Trends Anal. Chem.
– volume: 5
  start-page: 493
  year: 2010 May
  end-page: 504
  ident: bib48
  article-title: Pretreatment of Siam weed stem by several chemical methods for increasing the enzymatic digestibility
  publication-title: Biotechnol. J.
– volume: 80
  start-page: 275
  year: 2007 Apr
  end-page: 285
  ident: bib28
  article-title: Quantitative monitoring of extracellular matrix production in bone implants by 13C and 31P solid-state nuclear magnetic resonance spectroscopy
  publication-title: Calcif. Tissue Int.
– volume: 26
  year: 2022 Dec 24
  ident: bib30
  article-title: Quantitative detection of THz-ATR spectra of aqueous samples under strong-field terahertz wave
  publication-title: iScience
– volume: 44
  start-page: 1526
  year: 2024 Jul
  end-page: 1536
  ident: bib5
  article-title: The first MASH drug therapy on the horizon: current perspectives of resmetirom
  publication-title: Liver Int.
– volume: 337
  year: 1997
  ident: bib42
  article-title: Accurate quantification of quartz and other phases by powder X-ray diffractometry
  publication-title: Anal. Chim. Acta
– volume: 50
  start-page: 1
  year: 2024 Jan
  end-page: 10
  ident: bib25
  article-title: Quantitative analysis of cephalexin in solid dosage form by Raman spectroscopy and chemometric tools
  publication-title: Drug Dev. Ind. Pharm.
– volume: 114
  start-page: 330
  year: 2015 Oct 10
  end-page: 340
  ident: bib16
  article-title: Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy
  publication-title: J. Pharm. Biomed. Anal.
– volume: 103
  start-page: 3364
  year: 2014 Nov
  end-page: 3376
  ident: bib33
  article-title: Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials
  publication-title: J Pharm Sci
– volume: 336
  start-page: 555
  year: 2018
  end-page: 566
  ident: bib18
  article-title: Feasibility of near infrared and Raman hyperspectral imaging combined with multivariate analysis to assess binary mixtures of food powders
  publication-title: Powder Technol.
– volume: 14
  year: 2021
  ident: bib10
  article-title: Quantitative analysis of binary mixtures of entecavir using solid-state analytical techniques with chemometric methods
  publication-title: Arab. J. Chem.
– volume: 50
  start-page: 532
  year: 2015
  end-page: 535
  ident: bib31
  article-title: Moisture sorption properties research of chemical reference substances based on dynamic vapor sorption analysis technology
  publication-title: Chin Pharm J
– volume: 27
  start-page: 1666
  year: 2016
  end-page: 1672
  ident: bib13
  article-title: Quantification of flupirtine maleate polymorphs using X-ray powder diffraction
  publication-title: Chin. Chem. Lett.
– volume: 199
  start-page: 679
  year: 2019 Jul 1
  end-page: 688
  ident: bib19
  article-title: Quantification of niclosamide polymorphic forms - a comparative study by Raman, NIR and MIR using chemometric techniques
  publication-title: Talanta
– volume: 398
  start-page: 33
  year: 2010 Oct 15
  end-page: 38
  ident: bib43
  article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern
  publication-title: Int J Pharm
– volume: 108
  start-page: 3575
  year: 2019 Nov
  end-page: 3581
  ident: bib14
  article-title: Univariate and multivariate models for determination of prasugrel base in the formulation of prasugrel hydrochloride using XRPD method
  publication-title: J Pharm Sci
– volume: 103
  start-page: 23
  year: 2020 Jan 1
  end-page: 39
  ident: bib20
  article-title: Anthocyanin profiling using UV-vis spectroscopy and liquid chromatography mass spectrometry
  publication-title: J. AOAC Int.
– volume: 179
  start-page: 141
  year: 1999
  end-page: 158
  ident: bib12
  publication-title: Int. J. Pharm.
– volume: 58
  start-page: 109
  year: 2001
  end-page: 130
  ident: bib46
  article-title: PLS-regression: a basic tool of chemometrics
  publication-title: Chemometr. Intell. Lab. Syst.
– volume: 63
  start-page: 80
  year: 2012 Apr 7
  end-page: 86
  ident: bib49
  article-title: A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam
  publication-title: J. Pharm. Biomed. Anal.
– volume: 29
  start-page: 2919
  year: 2023 Nov
  end-page: 2928
  ident: bib6
  article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
  publication-title: Nat Med
– volume: 140
  start-page: 130
  year: 2017
  end-page: 136
  ident: bib35
  article-title: Quantitative analysis of binary polymorphs mixtures of fusidic acid by diffuse reflectance FTIR spectroscopy, diffuse reflectance FT NIR spectroscopy, Raman spectroscopy and multivariate calibration
  publication-title: J. Pharm. Biomed. Anal.
– volume: 48
  start-page: 67
  year: 2001 May 16
  end-page: 90
  ident: bib3
  article-title: Characterization of the solid state: quantitative issues
  publication-title: Adv. Drug Deliv. Rev.
– volume: 77
  start-page: 350
  year: 2023 Apr
  end-page: 359
  ident: bib47
  article-title: Congruence concept for comparison of spectra
  publication-title: Appl. Spectrosc.
– volume: 369
  year: 2023
  ident: bib8
  article-title: Screening, packing systematics, Hansen solubility parameters and desolvation of resmetirom (MGL-3196) solvates
  publication-title: J. Mol. Liq.
– volume: 368
  start-page: 103
  year: 2009 Feb 23
  end-page: 108
  ident: bib4
  article-title: Characterization and monit-oring of pseudo-polymorphs in manufacturing process by NIR
  publication-title: Int J Pharm
– volume: 43
  start-page: 865
  year: 2007 Feb 19
  end-page: 872
  ident: bib37
  article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique
  publication-title: J. Pharm. Biomed. Anal.
– volume: 39
  start-page: 116
  year: 2011 May-Jun
  end-page: 141
  ident: bib27
  article-title: Solid-state nuclear magnetic resonance investigations of the nature, property, and activity of acid sites on solid catalysts
  publication-title: Solid State Nucl. Magn. Reson.
– volume: 287
  year: 2023 Feb 15
  ident: bib29
  article-title: Quantitative analysis of aqueous biomolecular mixtures by THz spectroscopy based on high-power LiNbO3 radiation source
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
– volume: 112
  start-page: 225
  year: 2023 Jan
  end-page: 229
  ident: bib24
  article-title: Quantitative monitoring of cocrystal polymorphisms in model tablets using transmission low-frequency Raman spectroscopy
  publication-title: J Pharm Sci
– volume: 433
  year: 2024 Feb 1
  ident: bib26
  article-title: Qualitative and quantitative studies of phthalates in extra virgin olive oil (EVOO) by surface-enhanced Raman spectroscopy (SERS) combined with long short term memory (LSTM) neural network
  publication-title: Food Chem.
– volume: 272
  year: 2022
  ident: bib45
  article-title: Quantitative analysis of solid dosage forms of Losartan potassium by Raman spectroscopy
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
– volume: 107
  start-page: 298
  year: 2015 Mar 25
  end-page: 303
  ident: bib44
  article-title: Quantification of febuxostat polymorphs using powder X-ray diffraction technique
  publication-title: J. Pharm. Biomed. Anal.
– volume: 61
  start-page: 6186
  year: 2022 Jul 20
  end-page: 6192
  ident: bib21
  article-title: Application of ultraviolet-visible spectroscopy coupled with support vector regression for the quantitative detection of thiamethoxam in tea
  publication-title: Appl. Opt.
– volume: 55
  start-page: 618
  year: 2011 Jun 25
  end-page: 644
  ident: bib32
  article-title: An overview of recent studies on the analysis of pharmaceutical polymorphs
  publication-title: J. Pharm. Biomed. Anal.
– volume: 90
  start-page: 186
  year: 2014 Mar
  end-page: 191
  ident: bib34
  article-title: Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC
  publication-title: J. Pharm. Biomed. Anal.
– volume: 23
  start-page: 9013
  year: 2022 Aug 12
  ident: bib2
  article-title: The relevance of crystal forms in the pharmaceutical field: sword of damocles or innovation tools?
  publication-title: Int. J. Mol. Sci.
– volume: 49
  start-page: 18
  year: 2009 Jan 15
  end-page: 25
  ident: bib22
  article-title: Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction
  publication-title: J. Pharm. Biomed. Anal.
– volume: 293
  year: 2023 May 15
  ident: bib11
  article-title: Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
– volume: 16
  start-page: 1109
  year: 1999 Jul
  end-page: 1113
  ident: bib52
  article-title: Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs
  publication-title: Pharm. Res. (N. Y.)
– volume: 49
  start-page: 338
  year: 2009 Feb 20
  end-page: 346
  ident: bib40
  article-title: Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study
  publication-title: J. Pharm. Biomed. Anal.
– volume: 398
  start-page: 33
  year: 2010 Oct 15
  end-page: 38
  ident: bib39
  article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern
  publication-title: Int J Pharm
– volume: 43
  start-page: 865
  year: 2007 Feb 19
  end-page: 872
  ident: bib50
  article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique
  publication-title: J. Pharm. Biomed. Anal.
– volume: 158
  start-page: 28
  year: 2018 Sep 5
  end-page: 37
  ident: bib23
  article-title: Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy
  publication-title: J. Pharm. Biomed. Anal.
– volume: 323
  year: 2024 Dec 15
  ident: bib15
  article-title: Quantitative determination of zearalenone in wheat by the CSA-NIR technique combined with chemometrics algorithms
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
– volume: 15
  start-page: 27
  year: 2021 Apr 24
  ident: bib17
  article-title: Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
  publication-title: BMC Chem
– year: 2006
  ident: bib1
  publication-title: The Pharmaceutical Industry
– volume: 51
  start-page: 866
  year: 2010 Mar 11
  end-page: 874
  ident: bib38
  article-title: Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction
  publication-title: J. Pharm. Biomed. Anal.
– volume: 245
  year: 2021 Jan 15
  ident: bib41
  article-title: Raman spectroscopy for the qualitative and quantitative analysis of solid dosage forms of Sitagliptin
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
– volume: 4
  start-page: 180
  year: 2014
  end-page: 184
  ident: bib9
  article-title: Effects of 900mhz mobile phone radiation on human thyroid hormone levels
  publication-title: Recent Pat. Biomarkers
– volume: 108
  start-page: 3575
  issue: 11
  year: 2019
  ident: 10.1016/j.talanta.2025.127568_bib14
  article-title: Univariate and multivariate models for determination of prasugrel base in the formulation of prasugrel hydrochloride using XRPD method
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2019.06.024
– volume: 21
  start-page: 869
  year: 2002
  ident: 10.1016/j.talanta.2025.127568_bib51
  article-title: Applications of Raman spectroscopy in pharmaceutical analysis
  publication-title: TrAC Trends Anal. Chem.
  doi: 10.1016/S0165-9936(02)01208-6
– volume: 51
  start-page: 866
  issue: 4
  year: 2010
  ident: 10.1016/j.talanta.2025.127568_bib38
  article-title: Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2009.09.021
– volume: 61
  start-page: 6186
  issue: 21
  year: 2022
  ident: 10.1016/j.talanta.2025.127568_bib21
  article-title: Application of ultraviolet-visible spectroscopy coupled with support vector regression for the quantitative detection of thiamethoxam in tea
  publication-title: Appl. Opt.
  doi: 10.1364/AO.463293
– volume: 44
  start-page: 1526
  issue: 7
  year: 2024
  ident: 10.1016/j.talanta.2025.127568_bib5
  article-title: The first MASH drug therapy on the horizon: current perspectives of resmetirom
  publication-title: Liver Int.
  doi: 10.1111/liv.15930
– volume: 323
  year: 2024
  ident: 10.1016/j.talanta.2025.127568_bib15
  article-title: Quantitative determination of zearalenone in wheat by the CSA-NIR technique combined with chemometrics algorithms
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
  doi: 10.1016/j.saa.2024.124858
– volume: 58
  start-page: 109
  issue: 2
  year: 2001
  ident: 10.1016/j.talanta.2025.127568_bib46
  article-title: PLS-regression: a basic tool of chemometrics
  publication-title: Chemometr. Intell. Lab. Syst.
  doi: 10.1016/S0169-7439(01)00155-1
– volume: 48
  start-page: 67
  issue: 1
  year: 2001
  ident: 10.1016/j.talanta.2025.127568_bib3
  article-title: Characterization of the solid state: quantitative issues
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(01)00099-0
– volume: 4
  start-page: 180
  issue: 3
  year: 2014
  ident: 10.1016/j.talanta.2025.127568_bib9
  article-title: Effects of 900mhz mobile phone radiation on human thyroid hormone levels
  publication-title: Recent Pat. Biomarkers
  doi: 10.2174/2210309005666150128003150
– volume: 103
  start-page: 3364
  issue: 11
  year: 2014
  ident: 10.1016/j.talanta.2025.127568_bib33
  article-title: Dynamic vapor sorption as a tool for characterization and quantification of amorphous content in predominantly crystalline materials
  publication-title: J Pharm Sci
  doi: 10.1002/jps.24160
– volume: 14
  year: 2021
  ident: 10.1016/j.talanta.2025.127568_bib10
  article-title: Quantitative analysis of binary mixtures of entecavir using solid-state analytical techniques with chemometric methods
  publication-title: Arab. J. Chem.
– volume: 336
  start-page: 555
  year: 2018
  ident: 10.1016/j.talanta.2025.127568_bib18
  article-title: Feasibility of near infrared and Raman hyperspectral imaging combined with multivariate analysis to assess binary mixtures of food powders
  publication-title: Powder Technol.
  doi: 10.1016/j.powtec.2018.06.025
– volume: 49
  start-page: 338
  issue: 2
  year: 2009
  ident: 10.1016/j.talanta.2025.127568_bib40
  article-title: Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2008.11.033
– volume: 29
  start-page: 2919
  issue: 11
  year: 2023
  ident: 10.1016/j.talanta.2025.127568_bib6
  article-title: Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
  publication-title: Nat Med
  doi: 10.1038/s41591-023-02603-1
– volume: 293
  year: 2023
  ident: 10.1016/j.talanta.2025.127568_bib11
  article-title: Quantitative analysis of low content polymorphic impurities in canagliflozin tablets by PXRD, NIR, ATR-FITR and Raman solid-state analysis techniques combined with stoichiometry
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
  doi: 10.1016/j.saa.2023.122458
– volume: 23
  start-page: 9013
  issue: 16
  year: 2022
  ident: 10.1016/j.talanta.2025.127568_bib2
  article-title: The relevance of crystal forms in the pharmaceutical field: sword of damocles or innovation tools?
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23169013
– volume: 368
  start-page: 103
  issue: 1–2
  year: 2009
  ident: 10.1016/j.talanta.2025.127568_bib4
  article-title: Characterization and monit-oring of pseudo-polymorphs in manufacturing process by NIR
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2008.10.010
– volume: 337
  year: 1997
  ident: 10.1016/j.talanta.2025.127568_bib42
  article-title: Accurate quantification of quartz and other phases by powder X-ray diffractometry
  publication-title: Anal. Chim. Acta
  doi: 10.1016/S0003-2670(96)00425-4
– year: 2006
  ident: 10.1016/j.talanta.2025.127568_bib1
– volume: 26
  issue: 1
  year: 2022
  ident: 10.1016/j.talanta.2025.127568_bib30
  article-title: Quantitative detection of THz-ATR spectra of aqueous samples under strong-field terahertz wave
  publication-title: iScience
  doi: 10.1016/j.isci.2022.105871
– volume: 103
  start-page: 23
  issue: 1
  year: 2020
  ident: 10.1016/j.talanta.2025.127568_bib20
  article-title: Anthocyanin profiling using UV-vis spectroscopy and liquid chromatography mass spectrometry
  publication-title: J. AOAC Int.
  doi: 10.5740/jaoacint.19-0201
– volume: 245
  year: 2021
  ident: 10.1016/j.talanta.2025.127568_bib41
  article-title: Raman spectroscopy for the qualitative and quantitative analysis of solid dosage forms of Sitagliptin
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
  doi: 10.1016/j.saa.2020.118900
– volume: 43
  start-page: 865
  issue: 3
  year: 2007
  ident: 10.1016/j.talanta.2025.127568_bib50
  article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2006.08.030
– volume: 55
  start-page: 618
  issue: 4
  year: 2011
  ident: 10.1016/j.talanta.2025.127568_bib32
  article-title: An overview of recent studies on the analysis of pharmaceutical polymorphs
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2010.12.020
– volume: 199
  start-page: 679
  year: 2019
  ident: 10.1016/j.talanta.2025.127568_bib19
  article-title: Quantification of niclosamide polymorphic forms - a comparative study by Raman, NIR and MIR using chemometric techniques
  publication-title: Talanta
  doi: 10.1016/j.talanta.2019.03.027
– volume: 16
  start-page: 1109
  issue: 7
  year: 1999
  ident: 10.1016/j.talanta.2025.127568_bib52
  article-title: Confocal Raman-spectroscopy: analytical approach to solid dispersions and mapping of drugs
  publication-title: Pharm. Res. (N. Y.)
  doi: 10.1023/A:1018956304595
– volume: 398
  start-page: 33
  issue: 1–2
  year: 2010
  ident: 10.1016/j.talanta.2025.127568_bib43
  article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2010.07.043
– volume: 63
  start-page: 80
  year: 2012
  ident: 10.1016/j.talanta.2025.127568_bib49
  article-title: A comparative study of the use of powder X-ray diffraction, Raman and near infrared spectroscopy for quantification of binary polymorphic mixtures of piracetam
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2012.01.013
– volume: 433
  year: 2024
  ident: 10.1016/j.talanta.2025.127568_bib26
  article-title: Qualitative and quantitative studies of phthalates in extra virgin olive oil (EVOO) by surface-enhanced Raman spectroscopy (SERS) combined with long short term memory (LSTM) neural network
  publication-title: Food Chem.
  doi: 10.1016/j.foodchem.2023.137300
– volume: 50
  start-page: 532
  issue: 6
  year: 2015
  ident: 10.1016/j.talanta.2025.127568_bib31
  article-title: Moisture sorption properties research of chemical reference substances based on dynamic vapor sorption analysis technology
  publication-title: Chin Pharm J
– volume: 28
  start-page: 1149
  issue: 6
  year: 2002
  ident: 10.1016/j.talanta.2025.127568_bib36
  article-title: Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry--exploring preferred orientation effects
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/S0731-7085(02)00053-5
– volume: 272
  year: 2022
  ident: 10.1016/j.talanta.2025.127568_bib45
  article-title: Quantitative analysis of solid dosage forms of Losartan potassium by Raman spectroscopy
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
  doi: 10.1016/j.saa.2022.120996
– volume: 43
  start-page: 865
  issue: 3
  year: 2007
  ident: 10.1016/j.talanta.2025.127568_bib37
  article-title: Quantification of olanzapine polymorphs using powder X-ray diffraction technique
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2006.08.030
– volume: 17
  year: 2024
  ident: 10.1016/j.talanta.2025.127568_bib7
  article-title: Resmetirom: the first food and drug administration-approved medication for nonalcoholic steatohepatitis (NASH)
  publication-title: Ann. Pharmacother.
– volume: 114
  start-page: 330
  year: 2015
  ident: 10.1016/j.talanta.2025.127568_bib16
  article-title: Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2015.06.011
– volume: 107
  start-page: 298
  year: 2015
  ident: 10.1016/j.talanta.2025.127568_bib44
  article-title: Quantification of febuxostat polymorphs using powder X-ray diffraction technique
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2015.01.005
– volume: 50
  start-page: 1
  issue: 1
  year: 2024
  ident: 10.1016/j.talanta.2025.127568_bib25
  article-title: Quantitative analysis of cephalexin in solid dosage form by Raman spectroscopy and chemometric tools
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1080/03639045.2023.2290021
– volume: 179
  start-page: 141
  year: 1999
  ident: 10.1016/j.talanta.2025.127568_bib12
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(98)00335-4
– volume: 77
  start-page: 350
  issue: 4
  year: 2023
  ident: 10.1016/j.talanta.2025.127568_bib47
  article-title: Congruence concept for comparison of spectra
  publication-title: Appl. Spectrosc.
  doi: 10.1177/00037028231152497
– volume: 90
  start-page: 186
  year: 2014
  ident: 10.1016/j.talanta.2025.127568_bib34
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2013.12.001
– volume: 140
  start-page: 130
  year: 2017
  ident: 10.1016/j.talanta.2025.127568_bib35
  article-title: Quantitative analysis of binary polymorphs mixtures of fusidic acid by diffuse reflectance FTIR spectroscopy, diffuse reflectance FT NIR spectroscopy, Raman spectroscopy and multivariate calibration
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2017.02.053
– volume: 80
  start-page: 275
  issue: 4
  year: 2007
  ident: 10.1016/j.talanta.2025.127568_bib28
  article-title: Quantitative monitoring of extracellular matrix production in bone implants by 13C and 31P solid-state nuclear magnetic resonance spectroscopy
  publication-title: Calcif. Tissue Int.
  doi: 10.1007/s00223-007-9007-3
– volume: 49
  start-page: 18
  issue: 1
  year: 2009
  ident: 10.1016/j.talanta.2025.127568_bib22
  article-title: Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2008.09.054
– volume: 39
  start-page: 116
  issue: 3–4
  year: 2011
  ident: 10.1016/j.talanta.2025.127568_bib27
  article-title: Solid-state nuclear magnetic resonance investigations of the nature, property, and activity of acid sites on solid catalysts
  publication-title: Solid State Nucl. Magn. Reson.
  doi: 10.1016/j.ssnmr.2011.03.007
– volume: 369
  year: 2023
  ident: 10.1016/j.talanta.2025.127568_bib8
  article-title: Screening, packing systematics, Hansen solubility parameters and desolvation of resmetirom (MGL-3196) solvates
  publication-title: J. Mol. Liq.
  doi: 10.1016/j.molliq.2022.120857
– volume: 5
  start-page: 493
  issue: 5
  year: 2010
  ident: 10.1016/j.talanta.2025.127568_bib48
  article-title: Pretreatment of Siam weed stem by several chemical methods for increasing the enzymatic digestibility
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.200900284
– volume: 158
  start-page: 28
  year: 2018
  ident: 10.1016/j.talanta.2025.127568_bib23
  article-title: Quantitation of polymorphic impurity in entecavir polymorphic mixtures using powder X-ray diffractometry and Raman spectroscopy
  publication-title: J. Pharm. Biomed. Anal.
  doi: 10.1016/j.jpba.2018.05.026
– volume: 112
  start-page: 225
  issue: 1
  year: 2023
  ident: 10.1016/j.talanta.2025.127568_bib24
  article-title: Quantitative monitoring of cocrystal polymorphisms in model tablets using transmission low-frequency Raman spectroscopy
  publication-title: J Pharm Sci
  doi: 10.1016/j.xphs.2022.09.009
– volume: 27
  start-page: 1666
  issue: 11
  year: 2016
  ident: 10.1016/j.talanta.2025.127568_bib13
  article-title: Quantification of flupirtine maleate polymorphs using X-ray powder diffraction
  publication-title: Chin. Chem. Lett.
  doi: 10.1016/j.cclet.2016.03.042
– volume: 15
  start-page: 27
  issue: 1
  year: 2021
  ident: 10.1016/j.talanta.2025.127568_bib17
  article-title: Quantitative analysis of doxorubicin hydrochloride and arterolane maleate by mid IR spectroscopy using transmission and reflectance modes
  publication-title: BMC Chem
  doi: 10.1186/s13065-021-00752-3
– volume: 287
  issue: Pt 2
  year: 2023
  ident: 10.1016/j.talanta.2025.127568_bib29
  article-title: Quantitative analysis of aqueous biomolecular mixtures by THz spectroscopy based on high-power LiNbO3 radiation source
  publication-title: Spectrochim. Acta Mol. Biomol. Spectrosc.
– volume: 398
  start-page: 33
  issue: 1–2
  year: 2010
  ident: 10.1016/j.talanta.2025.127568_bib39
  article-title: Quantitative analysis of crystalline pharmaceuticals in tablets by pattern-fitting procedure using X-ray diffraction pattern
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2010.07.043
SSID ssj0002303
Score 2.4618516
Snippet Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H2O, were...
Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H O, were...
Resmetirom is the first innovative drug for the treatment of non-alcoholic steatohepatitis (NASH), and its two crystal forms, form I and form-2H₂O, were...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 127568
SubjectTerms bioavailability
drugs
fatty liver
FTIR
humidity
Least-Squares Analysis
Multivariate Analysis
Polymorphism
PXRD
Quantitative
quantitative analysis
Raman
Resmetirom
Spectroscopy, Fourier Transform Infrared
Spectrum Analysis, Raman
Tablets
temperature
X-Ray Diffraction
Title Comparison of resmetirom quantative analysis in API and formulation models based on PXRD, FTIR and Raman scanning imaging combined with univariate and multivariate analyses
URI https://dx.doi.org/10.1016/j.talanta.2025.127568
https://www.ncbi.nlm.nih.gov/pubmed/39923672
https://www.proquest.com/docview/3165080636
https://www.proquest.com/docview/3242059606
Volume 287
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5CekgvJU36SNqELeQY2XrsQz4aN8ZuIQSTgG_LvgQKWE5iO8f-ov7IzqxWMYG0gR5XzKBhZ5j5RpoHIWfaScaM5okohUsA37JEB1u2TAODk5kLVb6XYnLDfsz5fIeMul4YLKuMvr_16cFbxyf9eJv9u7rGHl8IrpAf5DwAD_TDjEm08t6vbZkHQOw4eHeQIPW2i6d_i0MGQX4cP5TzHo46x4mrL8env-HPEIfG--RdBJB02Mr4nuz45oDsjbq9bYfk9-hptSBdVhTS6YVf1w_LBb3f6NBo9OipjrNIaN3Q4dUUzo4ifI3LvGhYkLOiGOMchfPVfPb9nI6vp7NAOtML3dCVbRce0XoRdh1RuERItIEDv-7STVM_ghwAZgNPKF3cPsD3-9UHcjO-uB5NkriTIbEFE-skr0qR-VxWHkzQpal1eWZTJwWrIPEpIH2rBkKXRjJjbemEl6XjvDAV5HFVmvriI9ltlo3_TKguhLWygGvXkKT73Jjccm_0QBvLjaiOSK_ThLprR2-oribtVkXVKVSdalV3RMpOX-qZDSkID6-xfuv0q0Bd-NNEN365WakiQwwLQE78gwZwDq4xSoHmU2scTxLj4N9CyPz4_4X7Qt7iCWsWMv6V7K4fNv4EoNDanAZbPyVvhtOfk8s_Nq4MaA
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9swDBaK7tBdhr3XPTlgxznxQ5KdY5EtSLauKIIUyE3Qy4ALxGmbpMf9ov3IkbLcYMAewI6SKVgWafGjTfFj7IN2JedGi0RW0iWIb3migy1brnGAKzMXsnzP5PSCf1mK5QEb92dhKK0y7v3dnh5269gzjKs5vGoaOuOLzhXjg1wE4IH78D2Ory_RGAy-7_M8EGPHyrujhMT3x3iGl1RlEB-A6g_lYkC1zqnk6u8d1J8AaHBEk4fsQUSQcNJN8hE78O1jdjTuiduesB_jO25BWNeA8fTKb5ub9QqudzqcNLr1oGMxEmhaODmfYdsB4dfI5gWBIWcD5OQcYPt8Of_0ESaL2TyIzvVKt7CxHeMRNKtAdgS4ihhp4wj6vAu7trnFeSCaDWNC7uK-g-7vN0_ZxeTzYjxNIilDYgsut0leVzLzeVl7tEGXptblmU1dKXmNkU-B8Vs9kroyJTfWVk76snJCFKbGQK5OU188Y4ftuvUvGOhCWlsWuOwao3SfG5Nb4Y0eaWOFkfUxG_SaUFdd7Q3VJ6Vdqqg6RapTneqOWdXrS_1iRAr9w7-Gvu_1q1Bd9NdEt36926giIxCLSE7-RQaBDvEYpSjzvDOOuxlT5d9ClvnL_5_cO3Y0XXw7Vaezs6-v2H26QgkMmXjNDrc3O_8GcdHWvA12_xM3ew32
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+resmetirom+quantative+analysis+in+API+and+formulation+models+based+on+PXRD%2C+FTIR+and+Raman+scanning+imaging+combined+with+univariate+and+multivariate+analyses&rft.jtitle=Talanta+%28Oxford%29&rft.au=Yang%2C+Chen&rft.au=Luo%2C+Ying&rft.au=Sun%2C+Wenxia&rft.au=Liu%2C+Xiangkui&rft.date=2025-05-15&rft.eissn=1873-3573&rft.volume=287&rft.spage=127568&rft_id=info:doi/10.1016%2Fj.talanta.2025.127568&rft_id=info%3Apmid%2F39923672&rft.externalDocID=39923672
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-9140&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-9140&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-9140&client=summon